Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Regular Use Effect of Inhaled Ipratropium Bromide in Asthma
NCT04167280Phase 4Completed
- Sponsor
- University of Saskatchewan
- Start
- Nov 2019
- Primary completion
- Mar 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of ipratropium bromide in asthma, sponsored by University of Saskatchewan. Started Nov 2019; status: completed.
02
Drugs
ipratropium bromide
03
Conditions
asthma
Beyond the preview
Go deeper on NCT04167280.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04167280.